+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angiotensin Inhibitor"

Global Cardiovascular Drugs Market by Drug Type (Angiotensin Inhibitors, Anticoagulants, Antihyperlipidemic), Disease Indication (Arrhythmia, Coronary Artery Disease, Hyperlipidaemia), Route of Administration, Mode of Purchase, End-Users - Forecast 2024-2030 - Product Thumbnail Image

Global Cardiovascular Drugs Market by Drug Type (Angiotensin Inhibitors, Anticoagulants, Antihyperlipidemic), Disease Indication (Arrhythmia, Coronary Artery Disease, Hyperlipidaemia), Route of Administration, Mode of Purchase, End-Users - Forecast 2024-2030

  • Report
  • May 2024
  • 185 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Angiotensin Inhibitor market is a segment of the Cardiovascular Drugs market. Angiotensin Inhibitors are drugs used to treat high blood pressure, heart failure, and other cardiovascular conditions. These drugs work by blocking the action of angiotensin, a hormone that causes blood vessels to constrict. This helps to reduce blood pressure and improve blood flow. Angiotensin Inhibitors are often used in combination with other drugs, such as diuretics, to achieve the desired effect. Angiotensin Inhibitors are available in both generic and branded forms. Commonly prescribed Angiotensin Inhibitors include ACE inhibitors, ARBs, and direct renin inhibitors. These drugs are available in both oral and injectable forms. Some companies in the Angiotensin Inhibitor market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more